Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Teclistamab Consolidation in NDMM
NCT06758375Phase 2Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Mar 2025
- Primary completion
- Sep 2026
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of teclistamab in multiple myeloma (MM), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Mar 2025; status: recruiting.
02
Drugs
teclistamab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06758375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06758375.